{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:29:30Z","timestamp":1780615770003,"version":"3.54.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ihj.2024.06.001","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T17:40:30Z","timestamp":1718214030000},"page":"197-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between Lipoprotein(a) concentration and adverse cardiac events in patients with coronary artery disease: An observational cohort study"],"prefix":"10.1016","volume":"76","author":[{"given":"Navaneeth","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Devasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobha Ullas","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Paramasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad Narayana","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesha","family":"Prakash N S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2024.06.001_bib1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jacl.2019.04.010","article-title":"Use of Lipoprotein(a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association","volume":"13","author":"Wilson","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ihj.2024.06.001_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.amjcard.2014.10.015","article-title":"Impact of lipoprotein(a) as residual risk on long-term outcomes in patients after percutaneous coronary intervention","volume":"115","author":"Konishi","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2024.06.001_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12265-021-10148-2","article-title":"The predictive value of Lp(a) for adverse cardiovascular event in ACS patients with an achieved LDL-C target at follow up after PCI","volume":"15","author":"Ren","year":"2022","journal-title":"J Cardiovasc Transl Res [Internet]"},{"key":"10.1016\/j.ihj.2024.06.001_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/hrt.2005.061895","article-title":"PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting","volume":"92","author":"Marcucci","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ihj.2024.06.001_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/clc.21988","article-title":"Lipoprotein(a), interleukin-10, C-reactive protein, and 8-year outcome after percutaneous coronary intervention","volume":"35","author":"Kardys","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ihj.2024.06.001_bib6","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2024.06.001_bib7","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J Lipid Res [Internet]"},{"key":"10.1016\/j.ihj.2024.06.001_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1258\/0004563021901937","article-title":"Effect of ageing on plasma lipoprotein(a) levels","volume":"39","author":"Akita","year":"2002","journal-title":"Ann Clin Biochem [Internet]"},{"key":"10.1016\/j.ihj.2024.06.001_bib10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jacl.2017.07.005","article-title":"Lipoprotein(a) screening in patients with controlled traditional risk factors undergoing percutaneous coronary intervention","volume":"11","author":"Weiss","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"9","key":"10.1016\/j.ihj.2024.06.001_bib11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jacc.2012.06.018","article-title":"Family history of premature death and risk of early onset cardiovascular disease","volume":"60","author":"Ranthe","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2024.06.001_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.33549\/physiolres.930511","article-title":"Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease","volume":"53","author":"Frohlich","year":"2004","journal-title":"Physiol Res [Internet]"},{"key":"10.1016\/j.ihj.2024.06.001_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1476-511X-13-65","article-title":"Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort","volume":"13","author":"Allard","year":"2014","journal-title":"Lipids Health Dis [Internet]"},{"key":"10.1016\/j.ihj.2024.06.001_bib14","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2169\/internalmedicine.4503-20","article-title":"Lipoprotein (a) and the risk of chronic kidney disease in hospitalized Japanese patients","volume":"59","author":"Tada","year":"2020","journal-title":"Intern Med [Internet]"},{"issue":"4","key":"10.1016\/j.ihj.2024.06.001_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","year":"2009","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.ihj.2024.06.001_bib16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/heartjnl-2020-316586","article-title":"Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease","volume":"106","author":"Liu","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.ihj.2024.06.001_bib17","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.ijcard.2012.05.007","article-title":"Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients","volume":"167","author":"Kwon","year":"2013","journal-title":"Int J Cardiol [Internet]"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483224000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483224000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T12:38:32Z","timestamp":1722256712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483224000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0019483224000749"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2024.06.001","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between Lipoprotein(a) concentration and adverse cardiac events in patients with coronary artery disease: An observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2024.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}